£415 million! Sartorius acquires recombinant albumin company Albumedix On August 8, the German life sciences group Sartorius announced that through its French-listed subsidiary Sartorius Stedim
BioNTech’s performance fell more than expected after four consecutive quarters of revenue of more than 5 billion euros ($5.1 billion) as demand for the new
There is no accident, let alone fluke, in the research and development of innovative drugs. Even if a star product has proven itself in many
Monkeypox, a smallpox-like virus, is causing global alarm. On July 23, the World Health Organization (WHO) declared monkeypox a global public health emergency (PHEIC). Over
Pfizer has been looking for assets in the biopharmaceutical space to expand its pipeline thanks to the big money it has made from COVID-19. Now,
On August 5, Merck announced that its novel non-nucleoside cytomegalovirus (CMV) inhibitor, Premin® (Litemovir Tablets), was officially launched in China for patients undergoing allogeneic hematopoietic
The distribution of passively targeted microparticles in vivo after intravenous injection first depends on the particle size. Nanocapsules or nanospheres smaller than 100 nm can
Targeted drugs refer to drugs or their preparations that are endowed with targeting ability. The purpose is to enable the drug or its carrier to
On August 1, Universal CAR-T (UCAR-T) pioneer Cellectis announced that the U.S. FDA has approved the company’s IND application for UCART20x22 to initiate this product
French pharmaceutical group Sanofi announced on Thursday that it will partner with Chinese biotech company Innovent Biologics to develop anti-cancer drugs for the Chinese market.
“When the capabilities of artificial intelligence (AI) surpass those of human beings, we will face two outcomes: immortality and death.” – Nick. Bostrom, AI ethics
On August 1, Johnson & Johnson/Janssen announced that the FDA approved an expanded indication of ustekinumab (Stelara) for the treatment of pediatric patients 6 years
